Literature DB >> 9739446

Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa.

L Baldini1, M Blini, A Guffanti, V Fossati, M Colombi, M L La Targia, F Bertoni, A Alietti, A Neri, G Bertoni.   

Abstract

BACKGROUND: The aim of this study was to assess clinicopathological characteristics and outcome in a series of primary ocular adnexal lymphomas (POALs). PATIENTS AND METHODS: Nineteen patients with localised (stage IE) POAL were followed for a median of 96 months (24-156). The diagnosis was based on surgical biopsies followed by immunohistochemistry in 16 cases or fine-needle aspiration followed by immunocytophenotypic analysis in three cases. Twelve patients were treated with local radiotherapy (RT), five with chemotherapy (CT), and two refused further therapy after apparently radical tumour removal achieved by the diagnostic excisional biopsy.
RESULTS: The histological and immunological pattern was consistent with a diagnosis of MALT-type lymphoma (11 cases), follicular center non-Hodgkin's lymphoma (three cases). a large-cell variant of Burkitt's lymphoma (one case), and large-cell transformed MALT lymphoma (one case). Low-grade lymphoma was diagnosed in the three cases which underwent fine-needle aspiration biopsy. All of the patients achieved and maintained complete remission except for those treated with surgical excision alone (two MALT conjunctival lymphoma cases): one of these relapsed locally, the other experienced the systemic spread of a transformed diffuse large-cell lymphoma and died 72 months after diagnosis. The side effects consisted of two cases of RT-related cataract after 52 and 72 months.
CONCLUSIONS: Regardless of histology, prognosis was excellent when surgery plus RT was adopted, and CT seems to be a valid alternative to RT. Surgery alone may be sub-optimal.

Entities:  

Mesh:

Year:  1998        PMID: 9739446     DOI: 10.1023/a:1008327301372

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  15 in total

1.  Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.

Authors:  C Auw-Haedrich; S E Coupland; A Kapp; A Schmitt-Gräff; R Buchen; H Witschel
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Orbital and ocular adnexal Mucosa-Associated Lymphoid Tissue (MALT) lymphomas: a single-center 10-year experience.

Authors:  M Smiljanic; R Milosevic; D Antic; B Andjelic; V Djurasinovic; M Todorovic; J Bila; A Bogdanovic; B Mihaljevic
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

3.  [Diseases of the lacrimal gland].

Authors:  N Fichter; M Schittkowski; R F Guthoff
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

4.  Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.

Authors:  Frédéric Charlotte; Kamal Doghmi; Nathalie Cassoux; Hongtao Ye; Ming-Qing Du; Michèle Kujas; Annette Lesot; George Mansour; Phuc Lehoang; Nicole Vignot; Frédérique Capron; Véronique Leblond
Journal:  Virchows Arch       Date:  2005-12-02       Impact factor: 4.064

5.  Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.

Authors:  S E Coupland; M Hellmich; C Auw-Haedrich; W R Lee; I Anagnostopoulos; H Stein
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

6.  Evolution of Care of Orbital Tumors with Radiation Therapy.

Authors:  Myrsini Ioakeim-Ioannidou; Shannon M MacDonald
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-24

7.  Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.

Authors:  Sarah E Coupland; Martin Hellmich; Claudia Auw-Haedrich; William R Lee; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

Review 8.  Extranodal marginal zone lymphoma of the ocular adnexa.

Authors:  Alexandra Stefanovic; Izidore S Lossos
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

Review 9.  A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma.

Authors:  Maurilio Ponzoni; Silvia Govi; Giada Licata; Silvia Mappa; Antonio Giordano Resti; Letterio S Politi; Lorenzo Spagnuolo; Eliana Di Cairano; Claudio Doglioni; Andrés J M Ferreri
Journal:  Oncologist       Date:  2013-06-28

Review 10.  [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].

Authors:  S E Coupland
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.